Therapeutic responses to antimalarial and antibacterial drugs in vivax malaria.

Therapeutic responses to antimalarial and antibacterial drugs in vivax malaria.

Plasmodium vivax is the most prevalent malaria infection and is an important cause of morbidity in Central and South America and Asia. P. vivax is generally sensitive to the common antimalarial drugs but high level resistance to chloroquine and/or pyrimethamine has been documented in some geographic...

Bibliografski detalji
Glavni autori:	Pukrittayakamee, S, Imwong, M, Looareesuwan, S, White, N
Format:	Journal article
Jezik:	English
Izdano:	2004

Slični predmeti

Therapeutic responses to different antimalarial drugs in vivax malaria.
od: Pukrittayakamee, S, i dr.
Izdano: (2000)

Therapeutic responses to antibacterial drugs in vivax malaria.
od: Pukrittayakamee, S, i dr.
Izdano: (2001)

Effects of different antimalarial drugs on gametocyte carriage in P. vivax malaria.
od: Pukrittayakamee, S, i dr.
Izdano: (2008)

Antimalarial effects of rifampin in Plasmodium vivax malaria.
od: Pukrittayakamee, S, i dr.
Izdano: (1994)

Blood stage antimalarial efficacy of primaquine in Plasmodium vivax malaria.
od: Pukrittayakamee, S, i dr.
Izdano: (1994)

In vitro efficacy of antimalarial drugs against Plasmodium vivax on the western border of Thailand.
od: Chotivanich, K, i dr.
Izdano: (2004)

Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial.
od: Phyo, A, i dr.
Izdano: (2016)

Antimalarial activity of KAF156 in falciparum and vivax malaria
od: Nosten, F, i dr.
Izdano: (2016)

Artesunate-dapsone-proguanil treatment of falciparum malaria: genotypic determinants of therapeutic response.
od: Krudsood, S, i dr.
Izdano: (2005)

Identification of cryptic coinfection with Plasmodium falciparum in patients presenting with vivax malaria.
od: Mayxay, M, i dr.
Izdano: (2001)

Abnormal circulatory control in falciparum malaria: the effects of antimalarial drugs.
od: Supanaranond, W, i dr.
Izdano: (1993)

Pulmonary oedema in vivax malaria.
od: Pukrittayakamee, S, i dr.
Izdano: (1998)

A systematic overview of published antimalarial drug trials.
od: Myint, H, i dr.
Izdano: (2004)

Contribution of humoral immunity to the therapeutic response in falciparum malaria.
od: Mayxay, M, i dr.
Izdano: (2001)

Therapeutic responses to quinine and clindamycin in multidrug-resistant falciparum malaria.
od: Pukrittayakamee, S, i dr.
Izdano: (2000)

Novel point mutations in the dihydrofolate reductase gene of Plasmodium vivax: evidence for sequential selection by drug pressure.
od: Imwong, M, i dr.
Izdano: (2003)

Antimalarial drug susceptibility of Plasmodium vivax in the Republic of Korea.
od: Chotivanich, K, i dr.
Izdano: (2009)

The mechanisms of parasite clearance after antimalarial treatment of Plasmodium falciparum malaria.
od: Chotivanich, K, i dr.
Izdano: (2000)

Practical PCR genotyping protocols for Plasmodium vivax using Pvcs and Pvmsp1.
od: Imwong, M, i dr.
Izdano: (2005)

Dyserythropoiesis and ineffective erythropoiesis in Plasmodium vivax malaria.
od: Wickramasinghe, SN, i dr.
Izdano: (1989)

Limited polymorphism in the dihydropteroate synthetase gene (dhps) of Plasmodium vivax isolates from Thailand.
od: Imwong, M, i dr.
Izdano: (2005)

A comparison of two short-course primaquine regimens for the treatment and radical cure of Plasmodium vivax malaria in Thailand.
od: Pukrittayakamee, S, i dr.
Izdano: (2010)

Population Pharmacokinetics and Antimalarial Pharmacodynamics of Piperaquine in Patients With Plasmodium vivax Malaria in Thailand.
od: Tarning, J, i dr.
Izdano: (2014)

Population pharmacokinetics and antimalarial pharmacodynamics of piperaquine in patients with plasmodium vivax malaria in Thailand
od: Tarning, J, i dr.
Izdano: (2014)

Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulfadoxine-pyrimethamine: Geographical and clinical correlates (vol 45, pg 3122, 2001)
od: Imwong, M, i dr.
Izdano: (2002)

Epidemiology of Plasmodium vivax malaria infection in Nepal
od: Rijal, KR, i dr.
Izdano: (2018)

Morbidity and mortality due to Plasmodium vivax malaria in Papua, Indonesia and its control using antimalarial drugs
od: Douglas, N
Izdano: (2011)

Erratum: Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulfadoxine-pyrimethamine: Geographical and clinical correlates (Antimicrobrial Agents and Chemotherapy (2001) 45:11 (3122-3127))
od: Imwong, M, i dr.
Izdano: (2002)

Transmission-blocking activity of antimalarials for Plasmodium vivax malaria in Anopheles darlingi.
od: Alice O Andrade, i dr.
Izdano: (2023-06-01)

Treatment of vivax malaria on the western border of Thailand.
od: Luxemburger, C, i dr.
Izdano: (1999)

Effects of Plasmodium vivax malaria in pregnancy.
od: Nosten, F, i dr.
Izdano: (1999)

The molecular basis of antimalarial drug resistance in Plasmodium vivax
od: Lucas E. Buyon, i dr.
Izdano: (2021-08-01)

Antimalarial bioavailability and disposition of artesunate in acute falciparum malaria.
od: Newton, P, i dr.
Izdano: (2000)

Plasmodium vivax recurrence following falciparum and mixed species malaria: risk factors and effect of antimalarial kinetics.
od: Douglas, N, i dr.
Izdano: (2011)

Practical PCR genotyping protocols for <it>Plasmodium vivax </it>using <it>Pvcs </it>and <it>Pvmsp1</it>
od: Looareesuwan Sornchai, i dr.
Izdano: (2005-04-01)

Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial.
od: Awab, G, i dr.
Izdano: (2010)

High rate of Plasmodium vivax relapse following treatment of falciparum malaria in Thailand.
od: Looareesuwan, S, i dr.
Izdano: (1987)

Haematinic treatment of anaemia increases the risk of Plasmodium vivax malaria in pregnancy.
od: Nacher, M, i dr.
Izdano: (2003)

Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study.
od: Mcgready, R, i dr.
Izdano: (2012)

Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: A population-based study
od: McGready, R, i dr.
Izdano: (2012)